- Home
- PSTV vs QNRX Comparison
PSTV vs QNRX Comparison
Compare PSTV & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- QNRX
- Stock Information
- Founded
- PSTV 1996
- QNRX 2018
- Country
- PSTV United States
- QNRX United States
- Employees
- PSTV N/A
- QNRX N/A
- Industry
- PSTV Medical/Dental Instruments
- QNRX Medical/Dental Instruments
- Sector
- PSTV Health Care
- QNRX Health Care
- Exchange
- PSTV Nasdaq
- QNRX Nasdaq
- Market Cap
- PSTV 2.1M
- QNRX 2.5M
- IPO Year
- PSTV N/A
- QNRX N/A
- Fundamental
- Price
- PSTV $0.79
- QNRX $7.12
- Analyst Decision
- PSTV Strong Buy
- QNRX
- Analyst Count
- PSTV 3
- QNRX 0
- Target Price
- PSTV $11.50
- QNRX N/A
- AVG Volume (30 Days)
- PSTV 3.8M
- QNRX 355.0K
- Earning Date
- PSTV 05-14-2025
- QNRX 05-08-2025
- Dividend Yield
- PSTV N/A
- QNRX N/A
- EPS Growth
- PSTV N/A
- QNRX N/A
- EPS
- PSTV N/A
- QNRX N/A
- Revenue
- PSTV $5,824,000.00
- QNRX N/A
- Revenue This Year
- PSTV $13.26
- QNRX N/A
- Revenue Next Year
- PSTV $24.59
- QNRX N/A
- P/E Ratio
- PSTV N/A
- QNRX N/A
- Revenue Growth
- PSTV 18.54
- QNRX N/A
- 52 Week Low
- PSTV $0.24
- QNRX $5.01
- 52 Week High
- PSTV $2.67
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- PSTV 47.37
- QNRX 46.54
- Support Level
- PSTV $0.61
- QNRX $5.27
- Resistance Level
- PSTV $1.22
- QNRX $7.22
- Average True Range (ATR)
- PSTV 0.13
- QNRX 1.12
- MACD
- PSTV 0.02
- QNRX 0.22
- Stochastic Oscillator
- PSTV 29.16
- QNRX 62.79
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.